Antifibrinolytic Agent [EPC]

Antifibrinolytic Agent [EPC] was reported 9841 times

Drugs of the Antifibrinolytic Agent [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MECHANICAL VENTILATION COMPLICATION 25 0.1678
1 POST PROCEDURAL HYPOTENSION 11 0.1294
2 INSPIRATORY CAPACITY DECREASED 26 0.0939
3 RENAL CORTICAL NECROSIS 17 0.0730
4 MESENTERIC VASCULAR INSUFFICIENCY 8 0.0727
5 OVARIAN VEIN THROMBOSIS 8 0.0530
6 RED BLOOD CELL TRANSFUSION 16 0.0390
7 HAEMOPHILIA 8 0.0374
8 FALLOPIAN TUBE DISORDER 11 0.0373
9 TRI-IODOTHYRONINE FREE DECREASED 9 0.0353
10 ADNEXAL TORSION 11 0.0347
11 ELECTROCARDIOGRAM PR SHORTENED 7 0.0333
12 CONGENITAL ORAL MALFORMATION 7 0.0320
13 PARENTERAL NUTRITION 7 0.0303
14 MATERNAL EXPOSURE DURING DELIVERY 30 0.0303
15 BILIARY SEPSIS 14 0.0302
16 DISABILITY ASSESSMENT SCALE SCORE INCREASED 9 0.0293
17 HAEMOPHILIC ARTHROPATHY 7 0.0293
18 FIBRIN DEGRADATION PRODUCTS INCREASED 8 0.0270
19 ENTEROCOCCAL SEPSIS 21 0.0259
20 CEREBRAL VENOUS SINUS THROMBOSIS 21 0.0249
21 BONE MARROW RETICULIN FIBROSIS 6 0.0233
22 DREAMY STATE 7 0.0216
23 ACUTE LEFT VENTRICULAR FAILURE 14 0.0208
24 APLASTIC ANAEMIA 105 0.0201
25 JOINT ANKYLOSIS 11 0.0194
26 FACTOR VIII INHIBITION 19 0.0181
27 INFUSION SITE SCAR 8 0.0181
28 MYOCLONIC EPILEPSY 27 0.0178
29 HAEMOTHORAX 51 0.0176
30 PLATELET TRANSFUSION 20 0.0155
31 SPONTANEOUS HAEMORRHAGE 15 0.0146
32 BASOPHIL COUNT INCREASED 10 0.0132
33 WRONG PRODUCT ADMINISTERED 88 0.0130
34 VASODILATATION 32 0.0127
35 PERFORATION 10 0.0124
36 ANTI FACTOR VIII ANTIBODY POSITIVE 7 0.0124
37 FIBROMA 11 0.0120
38 HAEMORRHAGIC DISORDER 13 0.0119
39 CORONARY ARTERY THROMBOSIS 24 0.0119
40 STRIDOR 35 0.0119
41 POSTPARTUM HAEMORRHAGE 16 0.0119
42 TRAUMATIC HAEMORRHAGE 22 0.0117
43 CEREBRAL ARTERY THROMBOSIS 6 0.0117
44 BRONCHIAL HYPERREACTIVITY 14 0.0116
45 HEREDITARY ANGIOEDEMA 124 0.0115
46 URINE LEUKOCYTE ESTERASE POSITIVE 8 0.0114
47 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 12 0.0113
48 MYOCLONUS 133 0.0111
49 HYPORESPONSIVE TO STIMULI 13 0.0111
50 PRODUCT APPEARANCE CONFUSION 10 0.0108
51 PRODUCT PACKAGING CONFUSION 26 0.0107
52 NEONATAL RESPIRATORY DISTRESS 10 0.0106
53 PUNCTURE SITE HAEMORRHAGE 7 0.0099
54 UTERINE DISORDER 23 0.0099
55 IMMUNE THROMBOCYTOPENIA 45 0.0098
56 VASCULAR STENT THROMBOSIS 20 0.0098
57 DYSCHROMATOPSIA 8 0.0097
58 ARTERIAL HAEMORRHAGE 11 0.0096
59 HAEMARTHROSIS 79 0.0088
60 ABSCESS ORAL 12 0.0087
61 INFUSION SITE DISCOMFORT 9 0.0087
62 GASTROINTESTINAL VIRAL INFECTION 9 0.0086
63 SHOCK HAEMORRHAGIC 69 0.0085
64 STATUS EPILEPTICUS 95 0.0084
65 MOUTH HAEMORRHAGE 61 0.0083
66 RETINAL ARTERY OCCLUSION 21 0.0083
67 DIABETES INSIPIDUS 20 0.0083
68 PCO2 DECREASED 8 0.0083
69 NAIL INFECTION 11 0.0077
70 TONGUE HAEMORRHAGE 9 0.0077
71 LOWER RESPIRATORY TRACT CONGESTION 13 0.0076
72 JOINT NOISE 15 0.0076
73 BLOOD FIBRINOGEN INCREASED 6 0.0076
74 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 10 0.0076
75 SYSTOLIC DYSFUNCTION 8 0.0076
76 UPPER RESPIRATORY TRACT INFLAMMATION 9 0.0075
77 PHARYNGEAL HAEMORRHAGE 9 0.0073
78 INFERTILITY 11 0.0073
79 NOSOCOMIAL INFECTION 16 0.0073
80 MUSCLE HAEMORRHAGE 29 0.0072
81 SLEEP DEFICIT 15 0.0071
82 LIP HAEMORRHAGE 9 0.0071
83 BLOOD FIBRINOGEN DECREASED 8 0.0070
84 URINE KETONE BODY PRESENT 11 0.0070
85 GENERALISED TONIC-CLONIC SEIZURE 113 0.0068
86 OESOPHAGEAL HAEMORRHAGE 9 0.0068
87 LABILE BLOOD PRESSURE 8 0.0067
88 INFUSION SITE WARMTH 8 0.0065
89 COAGULATION TIME PROLONGED 10 0.0065
90 BRAIN STEM HAEMORRHAGE 6 0.0063
91 UTERINE HAEMORRHAGE 27 0.0063
92 HEAVY MENSTRUAL BLEEDING 57 0.0063
93 ISCHAEMIC CEREBRAL INFARCTION 7 0.0060
94 PROCALCITONIN INCREASED 7 0.0060
95 EMBOLISM VENOUS 18 0.0059
96 NEUTROPENIC SEPSIS 42 0.0059
97 VENOOCCLUSIVE LIVER DISEASE 29 0.0059
98 CANCER PAIN 15 0.0059
99 INFUSION SITE RASH 8 0.0058
100 HYPOVOLAEMIA 34 0.0058
101 HAEMOGLOBIN INCREASED 26 0.0057
102 PULMONARY HAEMORRHAGE 43 0.0055
103 VENA CAVA THROMBOSIS 9 0.0054
104 TONIC CLONIC MOVEMENTS 7 0.0054
105 LIP INJURY 7 0.0053
106 PLATELET COUNT ABNORMAL 32 0.0053
107 JAUNDICE NEONATAL 10 0.0053
108 ADMINISTRATION SITE PAIN 6 0.0052
109 PULMONARY ALVEOLAR HAEMORRHAGE 29 0.0052
110 CLONUS 14 0.0051
111 HAEMORRHAGIC DIATHESIS 18 0.0051
112 OLIGOMENORRHOEA 11 0.0050
113 PULSELESS ELECTRICAL ACTIVITY 21 0.0050
114 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 86 0.0050
115 ANGIOPATHY 28 0.0050
116 HAEMODYNAMIC INSTABILITY 38 0.0050
117 PERIPHERAL ARTERY THROMBOSIS 7 0.0050
118 PROCEDURAL HAEMORRHAGE 19 0.0049
119 PURPURA 42 0.0047
120 POST PROCEDURAL HAEMORRHAGE 55 0.0047
121 BLOOD PRESSURE DIASTOLIC ABNORMAL 12 0.0047
122 TENOSYNOVITIS 13 0.0047
123 GASTROINTESTINAL WALL THICKENING 7 0.0047
124 CARDIAC VENTRICULAR THROMBOSIS 6 0.0046
125 HAEMORRHAGIC TRANSFORMATION STROKE 7 0.0046
126 ISCHAEMIA 21 0.0046
127 TUMOUR HAEMORRHAGE 13 0.0046
128 CYSTITIS HAEMORRHAGIC 18 0.0045
129 POOR VENOUS ACCESS 46 0.0044
130 PERIORBITAL OEDEMA 23 0.0044
131 BLOOD LOSS ANAEMIA 10 0.0044
132 ANAPHYLACTIC REACTION 243 0.0044
133 HAEMORRHAGE 456 0.0044
134 ATRIAL THROMBOSIS 9 0.0043
135 DISINHIBITION 7 0.0043
136 VENOUS THROMBOSIS 17 0.0043
137 MUCOSAL INFLAMMATION 113 0.0043
138 HYPOVENTILATION 14 0.0043
139 TRANSFUSION 45 0.0043
140 IMMUNE THROMBOCYTOPENIC PURPURA 12 0.0042
141 URINARY TRACT OBSTRUCTION 10 0.0042
142 FEBRILE NEUTROPENIA 277 0.0042
143 FINE MOTOR SKILL DYSFUNCTION 12 0.0041
144 CEREBELLAR INFARCTION 7 0.0041
145 ARTERIAL THROMBOSIS 8 0.0041
146 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
147 ANAPHYLACTIC SHOCK 106 0.0041
148 AUTONOMIC NERVOUS SYSTEM IMBALANCE 12 0.0041
149 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 9 0.0041
150 COAGULOPATHY 68 0.0041
151 PNEUMONIA FUNGAL 16 0.0041
152 BACTERIAL TEST POSITIVE 9 0.0040
153 GINGIVAL BLEEDING 55 0.0040
154 RHEUMATOID NODULE 11 0.0040
155 PLEURITIC PAIN 11 0.0040
156 PLATELET DISORDER 10 0.0040
157 PLATELET COUNT INCREASED 51 0.0039
158 INTRACARDIAC THROMBUS 12 0.0039
159 HAEMOPTYSIS 106 0.0038
160 HYPERTRICHOSIS 7 0.0038
161 LANGUAGE DISORDER 8 0.0037
162 EMBOLIC STROKE 13 0.0037
163 PERIPHERAL ISCHAEMIA 15 0.0037
164 MELAENA 80 0.0036
165 INTRAVENTRICULAR HAEMORRHAGE 9 0.0036
166 CATHETER SITE HAEMORRHAGE 9 0.0036
167 UTERINE LEIOMYOMA 26 0.0036
168 OXYGEN SATURATION ABNORMAL 10 0.0035
169 ALLERGIC REACTION TO EXCIPIENT 7 0.0035
170 ABNORMAL UTERINE BLEEDING 9 0.0035
171 SMALL INTESTINAL HAEMORRHAGE 7 0.0035
172 BLOOD CHLORIDE INCREASED 6 0.0035
173 STAPHYLOCOCCAL SEPSIS 17 0.0034
174 VENTRICULAR FIBRILLATION 38 0.0034
175 DISSEMINATED INTRAVASCULAR COAGULATION 48 0.0034
176 NEUTROPENIC COLITIS 7 0.0034
177 FIBRIN D DIMER INCREASED 12 0.0034
178 CENTRAL VENOUS CATHETERISATION 10 0.0033
179 STRESS CARDIOMYOPATHY 19 0.0033
180 AMYLASE INCREASED 12 0.0032
181 BRAIN OEDEMA 41 0.0032
182 SPUTUM INCREASED 7 0.0032
183 ONYCHOMYCOSIS 14 0.0032
184 CEREBRAL INFARCTION 77 0.0031
185 PARESIS 7 0.0031
186 THROMBOPHLEBITIS 11 0.0031
187 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7 0.0031
188 RED CELL DISTRIBUTION WIDTH INCREASED 13 0.0031
189 MENINGITIS ASEPTIC 14 0.0031
190 HEPATOSPLENOMEGALY 8 0.0031
191 VENTRICULAR HYPOKINESIA 10 0.0031
192 FOOD ALLERGY 24 0.0031
193 VASCULAR DEVICE INFECTION 14 0.0031
194 LARYNGEAL OEDEMA 19 0.0031
195 URINE ABNORMALITY 14 0.0031
196 EPISTAXIS 230 0.0031
197 APLASIA 6 0.0031
198 RASH MACULO-PAPULAR 68 0.0031
199 HEPARIN-INDUCED THROMBOCYTOPENIA 15 0.0030
200 NEUROTOXICITY 53 0.0030
201 BRAIN HERNIATION 9 0.0030
202 CIRCULATORY COLLAPSE 51 0.0030
203 EMPHYSEMA 30 0.0030
204 PNEUMOTHORAX 47 0.0030
205 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 15 0.0030
206 PULMONARY INFARCTION 7 0.0030
207 ACUTE MYOCARDIAL INFARCTION 87 0.0029
208 BACTERAEMIA 35 0.0029
209 ENTEROCOLITIS 17 0.0029
210 NORMAL NEWBORN 16 0.0029
211 GRAND MAL CONVULSION 27 0.0029
212 IRON DEFICIENCY 13 0.0029
213 HYPOPNOEA 10 0.0029
214 INFUSION SITE PRURITUS 9 0.0028
215 ELECTROENCEPHALOGRAM ABNORMAL 9 0.0028
216 ANGIOEDEMA 126 0.0028
217 HYPOPHOSPHATAEMIA 21 0.0028
218 THROMBOTIC THROMBOCYTOPENIC PURPURA 10 0.0028
219 EAR SWELLING 6 0.0028
220 ACUTE MYELOID LEUKAEMIA 44 0.0028
221 HAEMORRHAGE SUBCUTANEOUS 10 0.0028
222 BLOOD PRESSURE DIASTOLIC INCREASED 13 0.0028
223 COLITIS ISCHAEMIC 19 0.0028
224 BRONCHOSPASM 40 0.0028
225 VENOOCCLUSIVE DISEASE 7 0.0028
226 ACUTE MYELOID LEUKAEMIA RECURRENT 6 0.0028
227 MOUTH SWELLING 16 0.0028
228 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 14 0.0027
229 VENTRICULAR ARRHYTHMIA 10 0.0027
230 FACE OEDEMA 46 0.0027
231 CONCUSSION 21 0.0027
232 HYPOXIA 95 0.0027
233 COMPARTMENT SYNDROME 7 0.0027
234 EXTRAVASATION 11 0.0027
235 URINARY TRACT DISORDER 12 0.0027
236 RADICULOPATHY 7 0.0027
237 HYPERCAPNIA 8 0.0027
238 SINUS TACHYCARDIA 37 0.0026
239 HYPERREFLEXIA 9 0.0026
240 BRONCHOPULMONARY ASPERGILLOSIS 20 0.0026
241 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 14 0.0026
242 BLOOD BLISTER 8 0.0026
243 UPPER GASTROINTESTINAL HAEMORRHAGE 43 0.0026
244 PHARYNGEAL SWELLING 25 0.0026
245 ESCHERICHIA BACTERAEMIA 6 0.0025
246 MULTIPLE ORGAN DYSFUNCTION SYNDROME 72 0.0025
247 MYELODYSPLASTIC SYNDROME 36 0.0025
248 PARTIAL SEIZURES 13 0.0025
249 HAEMORRHAGE INTRACRANIAL 37 0.0025
250 HAEMATOMA 64 0.0025
251 ISCHAEMIC STROKE 44 0.0025
252 BACTERIAL SEPSIS 8 0.0025
253 NYSTAGMUS 13 0.0024
254 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 19 0.0024
255 WOUND HAEMORRHAGE 9 0.0024
256 ANAPHYLACTOID REACTION 10 0.0024
257 DEVICE RELATED INFECTION 37 0.0024
258 PRODUCT LABEL CONFUSION 14 0.0024
259 LOW BIRTH WEIGHT BABY 19 0.0024
260 BK VIRUS INFECTION 8 0.0024
261 BLOOD DISORDER 19 0.0024
262 THROMBOTIC MICROANGIOPATHY 23 0.0024
263 TONGUE OEDEMA 9 0.0024
264 HYPERTHERMIA 18 0.0024
265 WEIGHT LOSS POOR 12 0.0023
266 VIRAL UPPER RESPIRATORY TRACT INFECTION 11 0.0023
267 HYPERAESTHESIA 19 0.0023
268 CARDIOGENIC SHOCK 33 0.0023
269 RIGHT VENTRICULAR FAILURE 16 0.0023
270 BLOOD ALBUMIN DECREASED 18 0.0023
271 VULVOVAGINAL DISCOMFORT 10 0.0023
272 PLATELET COUNT DECREASED 241 0.0023
273 SHOCK 52 0.0023
274 OESOPHAGEAL CANDIDIASIS 9 0.0023
275 ILEUS PARALYTIC 10 0.0022
276 VAGINAL HAEMORRHAGE 97 0.0022
277 CYANOSIS 35 0.0022
278 MATERNAL EXPOSURE DURING BREAST FEEDING 9 0.0022
279 POLYURIA 18 0.0022
280 HEPATIC CYTOLYSIS 28 0.0022
281 PULMONARY EMBOLISM 208 0.0022
282 BLOOD BILIRUBIN INCREASED 59 0.0022
283 PROCTALGIA 14 0.0022
284 PROTHROMBIN TIME PROLONGED 13 0.0022
285 URINE OUTPUT DECREASED 19 0.0022
286 TACHYCARDIA 193 0.0022
287 HYPERACUSIS 8 0.0021
288 ACUTE RESPIRATORY DISTRESS SYNDROME 38 0.0021
289 NEUTROPHIL COUNT INCREASED 22 0.0021
290 CEREBRAL ISCHAEMIA 11 0.0021
291 PROTEIN TOTAL DECREASED 8 0.0021
292 VENTRICULAR TACHYCARDIA 35 0.0021
293 CEREBRAL THROMBOSIS 6 0.0021
294 CONCOMITANT DISEASE AGGRAVATED 13 0.0021
295 PNEUMOCYSTIS JIROVECII PNEUMONIA 21 0.0021
296 MYOPATHY 18 0.0021
297 INFUSION SITE SWELLING 13 0.0021
298 HYPOALBUMINAEMIA 16 0.0021
299 TUMOUR LYSIS SYNDROME 18 0.0020
300 WOUND SECRETION 8 0.0020
301 ADVERSE REACTION 27 0.0020
302 LIVE BIRTH 17 0.0020
303 DEPRESSION SUICIDAL 7 0.0020
304 DERMATITIS CONTACT 23 0.0020
305 PREMATURE DELIVERY 32 0.0020
306 AZOTAEMIA 8 0.0020
307 OVARIAN CYST 20 0.0020
308 SUSPECTED OFF LABEL USE 9 0.0020
309 SEIZURE 230 0.0020
310 ORGAN FAILURE 8 0.0020
311 SUPRAVENTRICULAR TACHYCARDIA 19 0.0020
312 OBSTRUCTIVE AIRWAYS DISORDER 22 0.0020
313 THERAPEUTIC PRODUCT EFFECT DELAYED 9 0.0020
314 FEMORAL NECK FRACTURE 10 0.0019
315 CARDIAC ARREST 161 0.0019
316 EMBOLISM 16 0.0019
317 DEEP VEIN THROMBOSIS 125 0.0019
318 FOOD INTOLERANCE 7 0.0019
319 THROMBOCYTOSIS 7 0.0019
320 PARADOXICAL DRUG REACTION 7 0.0019
321 SENSITIVITY TO WEATHER CHANGE 10 0.0019
322 HAEMATEMESIS 48 0.0019
323 BLOOD LACTATE DEHYDROGENASE INCREASED 30 0.0019
324 THROMBOCYTOPENIA 211 0.0019
325 PLEURISY 11 0.0019
326 MULTI-ORGAN FAILURE 32 0.0018
327 HEPATIC FUNCTION ABNORMAL 69 0.0018
328 PAPULE 13 0.0018
329 HYPOTENSION 370 0.0018
330 FACE INJURY 7 0.0018
331 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
332 TACHYPNOEA 25 0.0018
333 PETECHIAE 19 0.0018
334 DIFFUSE LARGE B-CELL LYMPHOMA 14 0.0018
335 INTESTINAL ISCHAEMIA 10 0.0018
336 BLOOD CREATINE INCREASED 8 0.0018
337 RHINOVIRUS INFECTION 7 0.0018
338 ATRIOVENTRICULAR BLOCK COMPLETE 12 0.0018
339 INTERMENSTRUAL BLEEDING 10 0.0018
340 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 17 0.0018
341 PANCYTOPENIA 99 0.0018
342 CHOLESTASIS 34 0.0018
343 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 9 0.0018
344 HYPOKALAEMIA 81 0.0018
345 DRUG ERUPTION 31 0.0017
346 ONYCHOCLASIS 12 0.0017
347 OESOPHAGITIS 19 0.0017
348 BLOOD UREA INCREASED 29 0.0017
349 PREMATURE BABY 52 0.0017
350 NEPHROGENIC ANAEMIA 8 0.0017
351 GASTROINTESTINAL HAEMORRHAGE 144 0.0017
352 LIGAMENT SPRAIN 17 0.0017
353 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 94 0.0017
354 TOXIC EPIDERMAL NECROLYSIS 26 0.0017
355 ACIDOSIS 13 0.0017
356 HAEMOGLOBIN DECREASED 174 0.0017
357 ILEUS 21 0.0017
358 HAEMOLYSIS 13 0.0017
359 EOSINOPHIL COUNT INCREASED 14 0.0017
360 HAEMOLYTIC ANAEMIA 15 0.0017
361 PLEURAL EFFUSION 101 0.0017
362 LIP OEDEMA 7 0.0017
363 ADRENAL INSUFFICIENCY 20 0.0016
364 CEREBRAL HAEMORRHAGE 59 0.0016
365 LYMPHOCYTE COUNT DECREASED 29 0.0016
366 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
367 PNEUMONIA BACTERIAL 15 0.0016
368 STEVENS-JOHNSON SYNDROME 36 0.0016
369 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
370 ALANINE AMINOTRANSFERASE INCREASED 98 0.0016
371 C-REACTIVE PROTEIN INCREASED 58 0.0016
372 MUSCLE RIGIDITY 19 0.0016
373 RECTAL HAEMORRHAGE 68 0.0016
374 ESCHERICHIA INFECTION 13 0.0016
375 WRONG DRUG ADMINISTERED 14 0.0016
376 OXYGEN SATURATION DECREASED 88 0.0016
377 ACUTE RESPIRATORY FAILURE 30 0.0016
378 INFUSION SITE PAIN 20 0.0016
379 CAESAREAN SECTION 18 0.0015
380 CARDIOPULMONARY FAILURE 6 0.0015
381 SWOLLEN TONGUE 48 0.0015
382 FEELING OF BODY TEMPERATURE CHANGE 9 0.0015
383 GRAFT VERSUS HOST DISEASE 11 0.0015
384 DELIRIUM 53 0.0015
385 RASH ERYTHEMATOUS 73 0.0015
386 DERMATITIS BULLOUS 11 0.0015
387 BLOOD IRON DECREASED 18 0.0015
388 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
389 SEPSIS 167 0.0015
390 THERAPY NON-RESPONDER 67 0.0015
391 TOXIC SKIN ERUPTION 15 0.0015
392 ANAL ABSCESS 8 0.0015
393 GASTRIC HAEMORRHAGE 17 0.0015
394 HIATUS HERNIA 19 0.0015
395 GENERALISED OEDEMA 18 0.0015
396 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
397 ENTEROCOCCAL INFECTION 7 0.0014
398 GASTRIC ULCER HAEMORRHAGE 8 0.0014
399 RENAL FAILURE ACUTE 61 0.0014
400 APHASIA 43 0.0014
401 BLOOD THYROID STIMULATING HORMONE INCREASED 13 0.0014
402 INFLAMMATORY MARKER INCREASED 7 0.0014
403 HAND FRACTURE 10 0.0014
404 POST PROCEDURAL COMPLICATION 27 0.0014
405 MYDRIASIS 18 0.0014
406 SEPTIC SHOCK 61 0.0014
407 PSEUDOMONAS INFECTION 12 0.0014
408 LIMB INJURY 38 0.0014
409 TRANSAMINASES INCREASED 31 0.0014
410 BACTERIAL INFECTION 26 0.0014
411 MATERNAL EXPOSURE DURING PREGNANCY 124 0.0014
412 HEAD INJURY 44 0.0014
413 HYPERPROLACTINAEMIA 9 0.0014
414 HEPATITIS ACUTE 9 0.0014
415 SUBARACHNOID HAEMORRHAGE 14 0.0014
416 VASCULITIS 16 0.0014
417 WALKING AID USER 9 0.0014
418 DEPRESSED LEVEL OF CONSCIOUSNESS 54 0.0014
419 INTERSTITIAL LUNG DISEASE 66 0.0014
420 PNEUMONIA ASPIRATION 34 0.0014
421 LUNG INFILTRATION 12 0.0014
422 HEMIPARESIS 23 0.0014
423 BLOOD PRESSURE DECREASED 90 0.0014
424 ANAEMIA 258 0.0014
425 CARDIAC FAILURE ACUTE 9 0.0013
426 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
427 DIZZINESS POSTURAL 13 0.0013
428 ODYNOPHAGIA 8 0.0013
429 HYDRONEPHROSIS 10 0.0013
430 POSTOPERATIVE WOUND INFECTION 9 0.0013
431 CONTUSION 127 0.0013
432 MATERNAL EXPOSURE BEFORE PREGNANCY 9 0.0013
433 EPILEPSY 40 0.0013
434 RESPIRATORY DISTRESS 36 0.0013
435 GASTRITIS 34 0.0013
436 CHOLANGITIS 8 0.0013
437 SKIN LACERATION 14 0.0013
438 NEUTROPHIL COUNT DECREASED 52 0.0013
439 DUODENAL ULCER 9 0.0013
440 NECROSIS 7 0.0013
441 SUBDURAL HAEMATOMA 18 0.0013
442 HAEMATURIA 43 0.0013
443 AMENORRHOEA 22 0.0013
444 PALLOR 34 0.0012
445 PRURITUS GENERALISED 27 0.0012
446 RESPIRATORY FAILURE 91 0.0012
447 TENDERNESS 13 0.0012
448 ACUTE PULMONARY OEDEMA 7 0.0012
449 THROMBOSIS 100 0.0012
450 HEPATITIS C 15 0.0012
451 RESPIRATORY RATE INCREASED 11 0.0012
452 RASH PUSTULAR 9 0.0012
453 PERONEAL NERVE PALSY 7 0.0012
454 NODULE 16 0.0012
455 WHITE BLOOD CELL COUNT INCREASED 47 0.0012
456 MENORRHAGIA 24 0.0012
457 ORAL CANDIDIASIS 16 0.0012
458 HAEMATOCRIT DECREASED 24 0.0012
459 BRADYCARDIA 64 0.0012
460 UROSEPSIS 11 0.0012
461 IRON DEFICIENCY ANAEMIA 11 0.0012
462 EXPOSURE DURING PREGNANCY 74 0.0012
463 ACUTE KIDNEY INJURY 182 0.0012
464 METABOLIC ACIDOSIS 38 0.0012
465 PRODUCT DISTRIBUTION ISSUE 11 0.0012
466 TROPONIN INCREASED 9 0.0012
467 ENCEPHALOPATHY 29 0.0012
468 DEFORMITY 11 0.0012
469 FOOT DEFORMITY 13 0.0012
470 CACHEXIA 6 0.0012
471 GASTROENTERITIS 17 0.0012
472 HYPOCALCAEMIA 22 0.0012
473 BENIGN PROSTATIC HYPERPLASIA 6 0.0012
474 PULMONARY OEDEMA 52 0.0012
475 BLOOD URINE PRESENT 22 0.0012
476 HYPERBILIRUBINAEMIA 12 0.0012
477 PYREXIA 398 0.0011
478 ASPARTATE AMINOTRANSFERASE INCREASED 61 0.0011
479 FULL BLOOD COUNT ABNORMAL 12 0.0011
480 PULMONARY TOXICITY 8 0.0011
481 PHARYNGITIS 14 0.0011
482 HEPATIC FAILURE 34 0.0011
483 UNRESPONSIVE TO STIMULI 29 0.0011
484 DRUG INTERACTION 177 0.0011
485 LEUKOCYTOSIS 20 0.0011
486 PHARYNGEAL OEDEMA 17 0.0011
487 TOOTHACHE 20 0.0011
488 PRODUCT PRESCRIBING ISSUE 24 0.0011
489 COVID-19 PNEUMONIA 13 0.0011
490 SALIVARY HYPERSECRETION 11 0.0011
491 NERVE INJURY 12 0.0011
492 MALNUTRITION 12 0.0011
493 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
494 ARTERIOSCLEROSIS 10 0.0011
495 RESPIRATORY DEPRESSION 13 0.0011
496 MYOCARDIAL ISCHAEMIA 12 0.0011
497 GASTROENTERITIS VIRAL 19 0.0011
498 CARDIO-RESPIRATORY ARREST 44 0.0011
499 PARALYSIS 15 0.0010
500 ANURIA 9 0.0010
501 JOINT RANGE OF MOTION DECREASED 14 0.0010
502 PROCEDURAL COMPLICATION 8 0.0010
503 BLOOD CREATINE PHOSPHOKINASE INCREASED 30 0.0010
504 BLOOD URIC ACID INCREASED 6 0.0010
505 ATELECTASIS 10 0.0010
506 BONE MARROW FAILURE 21 0.0010
507 URTICARIA 173 0.0010
508 JOINT INJURY 22 0.0010
509 BODY TEMPERATURE INCREASED 21 0.0010
510 ACUTE HEPATIC FAILURE 14 0.0010
511 SPLENOMEGALY 12 0.0010
512 ASCITES 30 0.0010
513 DRUG-INDUCED LIVER INJURY 32 0.0010
514 KIDNEY INFECTION 20 0.0010
515 HYPOMAGNESAEMIA 14 0.0010
516 CYTOPENIA 12 0.0010
517 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
518 IMPAIRED QUALITY OF LIFE 14 0.0010
519 PARAESTHESIA ORAL 14 0.0010
520 EOSINOPHILIA 17 0.0010
521 HYPERKALAEMIA 34 0.0010
522 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
523 SPINAL COMPRESSION FRACTURE 8 0.0010
524 JAUNDICE 26 0.0010
525 ACUTE CORONARY SYNDROME 8 0.0010
526 TOOTH EXTRACTION 12 0.0010
527 RENAL IMPAIRMENT 81 0.0010
528 APPENDICITIS 9 0.0010
529 THERAPY PARTIAL RESPONDER 15 0.0010
530 DISORIENTATION 38 0.0010
531 SYNCOPE 95 0.0009
532 INFUSION SITE ERYTHEMA 8 0.0009
533 FACIAL PARALYSIS 8 0.0009
534 PRODUCT CONTAINER ISSUE 8 0.0009
535 HYPONATRAEMIA 52 0.0009
536 DISEASE PROGRESSION 109 0.0009
537 PNEUMONIA 298 0.0009
538 PNEUMONITIS 25 0.0009
539 HEPATOMEGALY 9 0.0009
540 ASPERGILLUS INFECTION 6 0.0009
541 WOUND INFECTION 10 0.0009
542 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
543 CYTOMEGALOVIRUS INFECTION 15 0.0009
544 LIP SWELLING 30 0.0009
545 FUNGAL INFECTION 30 0.0009
546 APNOEA 7 0.0009
547 URINARY RETENTION 30 0.0009
548 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
549 TORSADE DE POINTES 7 0.0009
550 SKIN INFECTION 10 0.0009
551 HYPERCALCAEMIA 11 0.0009
552 HYPOTHERMIA 9 0.0009
553 MOTOR DYSFUNCTION 9 0.0009
554 CHILLS 103 0.0009
555 PRESCRIBED OVERDOSE 17 0.0009
556 ATRIAL FLUTTER 7 0.0009
557 JOINT STIFFNESS 23 0.0009
558 EYE MOVEMENT DISORDER 6 0.0009
559 MIOSIS 7 0.0009
560 PERICARDIAL EFFUSION 20 0.0009
561 PULMONARY HYPERTENSION 18 0.0009
562 WOUND 24 0.0009
563 ERYTHEMA MULTIFORME 8 0.0009
564 GENITAL HAEMORRHAGE 11 0.0009
565 BLOOD PRESSURE ABNORMAL 17 0.0009
566 FLANK PAIN 8 0.0009
567 HAEMATOCHEZIA 47 0.0009
568 JOINT DISLOCATION 9 0.0009
569 WHEEZING 50 0.0008
570 RED BLOOD CELL COUNT DECREASED 24 0.0008
571 SEROTONIN SYNDROME 16 0.0008
572 DYSMENORRHOEA 11 0.0008
573 OEDEMA PERIPHERAL 101 0.0008
574 PULMONARY THROMBOSIS 9 0.0008
575 LIVER FUNCTION TEST ABNORMAL 24 0.0008
576 EYE HAEMORRHAGE 11 0.0008
577 PRESYNCOPE 20 0.0008
578 ASPIRATION 9 0.0008
579 OFF LABEL USE 718 0.0008
580 LEUKOPENIA 41 0.0008
581 MIGRAINE 78 0.0008
582 TOOTH FRACTURE 9 0.0008
583 SWELLING FACE 53 0.0008
584 ATRIAL FIBRILLATION 79 0.0008
585 PYELONEPHRITIS 7 0.0008
586 HYPOTONIA 8 0.0008
587 MITRAL VALVE INCOMPETENCE 9 0.0008
588 INTENTIONAL SELF-INJURY 16 0.0008
589 OSTEOPENIA 12 0.0008
590 LIVER DISORDER 35 0.0008
591 COORDINATION ABNORMAL 11 0.0008
592 FOETAL EXPOSURE DURING PREGNANCY 64 0.0008
593 CARDIOTOXICITY 7 0.0008
594 HYPOGLYCAEMIA 38 0.0008
595 HYPOPHAGIA 20 0.0008
596 RENAL FAILURE 103 0.0008
597 PERITONITIS 16 0.0008
598 NEUTROPENIA 105 0.0008
599 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
600 HALLUCINATION, VISUAL 16 0.0008
601 HYPOKINESIA 11 0.0008
602 MEDICATION ERROR 42 0.0008
603 AGRANULOCYTOSIS 14 0.0008
604 ABDOMINAL PAIN 175 0.0008
605 CONVULSION 43 0.0008
606 HYPERTENSION 159 0.0007
607 HEPATIC ENCEPHALOPATHY 7 0.0007
608 BLOOD PRESSURE FLUCTUATION 18 0.0007
609 CARDIOVASCULAR DISORDER 19 0.0007
610 PHOTOPHOBIA 14 0.0007
611 NO THERAPEUTIC RESPONSE 9 0.0007
612 COLD SWEAT 13 0.0007
613 HEART RATE INCREASED 73 0.0007
614 DECUBITUS ULCER 6 0.0007
615 RASH GENERALISED 19 0.0007
616 INTENTIONAL PRODUCT USE ISSUE 64 0.0007
617 RESPIRATORY ARREST 20 0.0007
618 BLOOD PRESSURE INCREASED 110 0.0007
619 RHABDOMYOLYSIS 30 0.0007
620 ARRHYTHMIA 34 0.0007
621 HAEMORRHOIDS 14 0.0007
622 COLITIS 27 0.0007
623 BODY TEMPERATURE DECREASED 7 0.0007
624 TENDONITIS 11 0.0007
625 WHITE BLOOD CELL COUNT DECREASED 77 0.0007
626 LUNG INFECTION 11 0.0007
627 BLADDER DISORDER 7 0.0007
628 RESPIRATORY DISORDER 21 0.0007
629 HYPERSENSITIVITY 129 0.0007
630 RESPIRATORY TRACT INFECTION 18 0.0007
631 EYELID OEDEMA 8 0.0007
632 LOSS OF CONSCIOUSNESS 88 0.0007
633 ANHEDONIA 18 0.0007
634 VOMITING 322 0.0007
635 RESTLESSNESS 25 0.0007
636 OEDEMA 37 0.0007
637 BLISTER 38 0.0007
638 NEUROLEPTIC MALIGNANT SYNDROME 8 0.0007
639 BLOOD CREATININE INCREASED 44 0.0007
640 CHOLECYSTITIS 8 0.0007
641 QUALITY OF LIFE DECREASED 9 0.0007
642 FEAR 18 0.0007
643 AGITATION 49 0.0007
644 DRUG LEVEL INCREASED 11 0.0007
645 CHEST PAIN 123 0.0007
646 HYPOAESTHESIA ORAL 10 0.0007
647 PELVIC PAIN 12 0.0007
648 CLOSTRIDIUM DIFFICILE COLITIS 7 0.0007
649 PRODUCT AVAILABILITY ISSUE 15 0.0007
650 SWELLING 61 0.0007
651 MUSCLE TWITCHING 15 0.0007
652 DIVERTICULITIS 18 0.0006
653 BRONCHITIS 48 0.0006
654 CYTOKINE RELEASE SYNDROME 13 0.0006
655 ABNORMAL WEIGHT GAIN 8 0.0006
656 MUSCULOSKELETAL CHEST PAIN 10 0.0006
657 NECK PAIN 36 0.0006
658 MASS 9 0.0006
659 PRODUCT ADMINISTRATION ERROR 13 0.0006
660 BLINDNESS UNILATERAL 9 0.0006
661 HYPERGLYCAEMIA 23 0.0006
662 INTRAOCULAR PRESSURE INCREASED 8 0.0006
663 INTESTINAL PERFORATION 7 0.0006
664 PANCREATITIS ACUTE 14 0.0006
665 LYMPHADENOPATHY 22 0.0006
666 EYE PAIN 35 0.0006
667 REBOUND EFFECT 7 0.0006
668 FLUID OVERLOAD 9 0.0006
669 MALIGNANT NEOPLASM PROGRESSION 63 0.0006
670 PLASMA CELL MYELOMA 24 0.0006
671 SCAB 7 0.0006
672 NASAL CONGESTION 36 0.0006
673 CARDIAC FAILURE 49 0.0006
674 CARDIOMYOPATHY 9 0.0006
675 STAPHYLOCOCCAL INFECTION 20 0.0006
676 RENAL INJURY 18 0.0006
677 GENERAL PHYSICAL HEALTH DETERIORATION 70 0.0006
678 CONJUNCTIVITIS 11 0.0006
679 HERPES ZOSTER 34 0.0006
680 FEEDING DISORDER 12 0.0006
681 DRUG LEVEL DECREASED 6 0.0006
682 INSURANCE ISSUE 9 0.0006
683 PRODUCT PRESCRIBING ERROR 14 0.0006
684 LACTIC ACIDOSIS 19 0.0006
685 PRODUCT USE IN UNAPPROVED INDICATION 145 0.0006
686 POLYNEUROPATHY 7 0.0006
687 TOOTH DISORDER 13 0.0006
688 ABDOMINAL DISTENSION 61 0.0006
689 BLOOD SODIUM DECREASED 11 0.0006
690 MUSCLE SPASMS 107 0.0006
691 PERIPHERAL COLDNESS 8 0.0006
692 DYSPHONIA 34 0.0006
693 ORAL PAIN 13 0.0006
694 PARANOIA 10 0.0006
695 EJECTION FRACTION DECREASED 9 0.0006
696 GASTRIC ULCER 11 0.0006
697 PROTEINURIA 11 0.0006
698 PROCEDURAL PAIN 16 0.0006
699 MENTAL STATUS CHANGES 16 0.0006
700 FEELING COLD 16 0.0006
701 FEELING HOT 35 0.0006
702 HEART RATE DECREASED 20 0.0006
703 SMALL INTESTINAL OBSTRUCTION 7 0.0006
704 CHEST DISCOMFORT 58 0.0006
705 HEAD DISCOMFORT 10 0.0006
706 EAR INFECTION 15 0.0006
707 CONFUSIONAL STATE 91 0.0006
708 INTENTIONAL OVERDOSE 36 0.0006
709 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
710 BACK PAIN 130 0.0006
711 DYSPNOEA 316 0.0006
712 INFUSION RELATED REACTION 37 0.0006
713 TREATMENT FAILURE 46 0.0006
714 BLOOD POTASSIUM INCREASED 9 0.0006
715 FAECES DISCOLOURED 12 0.0006
716 MENTAL DISORDER 24 0.0006
717 PREGNANCY 11 0.0005
718 INFLUENZA 61 0.0005
719 PHOTOSENSITIVITY REACTION 9 0.0005
720 METASTASES TO CENTRAL NERVOUS SYSTEM 7 0.0005
721 BLINDNESS 22 0.0005
722 DRUG INEFFECTIVE 709 0.0005
723 BEDRIDDEN 7 0.0005
724 HEPATIC CIRRHOSIS 10 0.0005
725 PULMONARY CONGESTION 7 0.0005
726 FLATULENCE 30 0.0005
727 COVID-19 92 0.0005
728 ANGINA PECTORIS 15 0.0005
729 MOUTH ULCERATION 11 0.0005
730 PALPITATIONS 61 0.0005
731 FREQUENT BOWEL MOVEMENTS 14 0.0005
732 ELECTROLYTE IMBALANCE 6 0.0005
733 DYSURIA 19 0.0005
734 DIARRHOEA 331 0.0005
735 LIVER FUNCTION TEST INCREASED 11 0.0005
736 INJURY 36 0.0005
737 INFECTION 74 0.0005
738 OROPHARYNGEAL PAIN 47 0.0005
739 LETHARGY 29 0.0005
740 APHONIA 7 0.0005
741 ABSCESS 8 0.0005
742 CONTRAINDICATED PRODUCT ADMINISTERED 15 0.0005
743 THERAPEUTIC RESPONSE DECREASED 30 0.0005
744 DYSKINESIA 20 0.0005
745 RASH PAPULAR 11 0.0005
746 FALL 163 0.0005
747 LUNG DISORDER 24 0.0005
748 RIB FRACTURE 10 0.0005
749 PRODUCT USE ISSUE 91 0.0005
750 MUSCULAR WEAKNESS 55 0.0005
751 NEUROPATHY PERIPHERAL 46 0.0005
752 HEPATIC STEATOSIS 9 0.0005
753 PULMONARY ARTERIAL HYPERTENSION 7 0.0005
754 THROAT TIGHTNESS 13 0.0005
755 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
756 TINNITUS 22 0.0005
757 STOMATITIS 29 0.0005
758 BONE PAIN 28 0.0005
759 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
760 DYSPHAGIA 45 0.0005
761 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
762 URINARY INCONTINENCE 14 0.0005
763 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
764 DECREASED APPETITE 109 0.0005
765 METRORRHAGIA 8 0.0005
766 THERAPEUTIC PRODUCT EFFECT DECREASED 21 0.0005
767 BLOOD POTASSIUM DECREASED 14 0.0005
768 NIGHT SWEATS 15 0.0005
769 NAUSEA 367 0.0005
770 COUGH 130 0.0005
771 DISTURBANCE IN ATTENTION 25 0.0005
772 ERYTHEMA 95 0.0005
773 WEIGHT DECREASED 129 0.0005
774 SOMNOLENCE 93 0.0005
775 NEOPLASM PROGRESSION 16 0.0005
776 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
777 TREMOR 76 0.0005
778 HIP ARTHROPLASTY 7 0.0005
779 TREATMENT NONCOMPLIANCE 25 0.0005
780 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
781 MYALGIA 77 0.0005
782 NEURALGIA 11 0.0005
783 URINARY TRACT INFECTION 77 0.0005
784 RASH 194 0.0004
785 MYELOSUPPRESSION 16 0.0004
786 EXTRAPYRAMIDAL DISORDER 11 0.0004
787 ARTHRALGIA 184 0.0004
788 PRODUCTIVE COUGH 21 0.0004
789 CONDITION AGGRAVATED 133 0.0004
790 SUICIDAL IDEATION 40 0.0004
791 DEHYDRATION 58 0.0004
792 ANXIETY 123 0.0004
793 RASH MACULAR 15 0.0004
794 VISUAL IMPAIRMENT 53 0.0004
795 CHOLELITHIASIS 14 0.0004
796 DYSPEPSIA 42 0.0004
797 CONSTIPATION 93 0.0004
798 CEREBROVASCULAR ACCIDENT 72 0.0004
799 OSTEOARTHRITIS 18 0.0004
800 FLUSHING 43 0.0004
801 RETCHING 9 0.0004
802 MALAISE 185 0.0004
803 VIRAL INFECTION 14 0.0004
804 AGGRESSION 21 0.0004
805 PERIPHERAL SWELLING 64 0.0004
806 CANDIDA INFECTION 7 0.0004
807 ANOSMIA 6 0.0004
808 HYPOAESTHESIA 62 0.0004
809 LOCALISED INFECTION 10 0.0004
810 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
811 MENTAL IMPAIRMENT 10 0.0004
812 PANIC ATTACK 15 0.0004
813 HEADACHE 258 0.0004
814 DIZZINESS 204 0.0004
815 ILLNESS 42 0.0004
816 COGNITIVE DISORDER 19 0.0004
817 DISABILITY 8 0.0004
818 WEIGHT INCREASED 90 0.0004
819 INSOMNIA 107 0.0004
820 NASOPHARYNGITIS 74 0.0004
821 AGEUSIA 10 0.0004
822 SINUSITIS 41 0.0004
823 CELLULITIS 20 0.0004
824 HEPATIC ENZYME INCREASED 27 0.0004
825 IMPAIRED HEALING 13 0.0004
826 ECONOMIC PROBLEM 6 0.0004
827 LOWER RESPIRATORY TRACT INFECTION 18 0.0004
828 DISCOMFORT 24 0.0004
829 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
830 THIRST 7 0.0004
831 SKIN DISCOLOURATION 18 0.0004
832 GASTROINTESTINAL DISORDER 35 0.0004
833 GOUT 7 0.0004
834 ABDOMINAL DISCOMFORT 65 0.0004
835 CRYING 14 0.0004
836 END STAGE RENAL DISEASE 7 0.0004
837 UNEVALUABLE EVENT 29 0.0004
838 ROAD TRAFFIC ACCIDENT 16 0.0004
839 DIABETES MELLITUS 29 0.0004
840 HYPERHIDROSIS 49 0.0004
841 KNEE ARTHROPLASTY 8 0.0004
842 DISEASE RECURRENCE 18 0.0004
843 MYOCARDIAL INFARCTION 66 0.0004
844 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
845 PARAESTHESIA 59 0.0004
846 MOVEMENT DISORDER 12 0.0004
847 TOXICITY TO VARIOUS AGENTS 63 0.0004
848 PAIN 229 0.0004
849 DYSPNOEA EXERTIONAL 14 0.0004
850 POOR QUALITY SLEEP 8 0.0004
851 VISION BLURRED 51 0.0004
852 PAIN IN EXTREMITY 109 0.0004
853 LIVER INJURY 9 0.0004
854 IRRITABILITY 22 0.0004
855 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
856 CORONARY ARTERY DISEASE 11 0.0004
857 SPEECH DISORDER 19 0.0004
858 EXPIRED PRODUCT ADMINISTERED 12 0.0004
859 GAIT DISTURBANCE 69 0.0004
860 POLLAKIURIA 15 0.0004
861 PANCREATITIS 19 0.0004
862 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
863 ORAL HERPES 7 0.0004
864 HOT FLUSH 27 0.0004
865 TYPE 2 DIABETES MELLITUS 12 0.0004
866 JOINT SWELLING 43 0.0004
867 ABDOMINAL PAIN LOWER 9 0.0004
868 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
869 LIMB DISCOMFORT 11 0.0004
870 ACCIDENTAL OVERDOSE 13 0.0004
871 FEMUR FRACTURE 11 0.0004
872 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
873 UPPER LIMB FRACTURE 7 0.0004
874 RASH PRURITIC 19 0.0004
875 INFLAMMATION 18 0.0003
876 SUICIDE ATTEMPT 21 0.0003
877 DYSARTHRIA 13 0.0003
878 MUSCULOSKELETAL PAIN 18 0.0003
879 SURGERY 20 0.0003
880 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 61 0.0003
881 TOOTH LOSS 7 0.0003
882 NO ADVERSE EVENT 61 0.0003
883 COMA 16 0.0003
884 ABDOMINAL PAIN UPPER 69 0.0003
885 DERMATITIS 7 0.0003
886 HALLUCINATION 25 0.0003
887 MOOD ALTERED 9 0.0003
888 FIBROMYALGIA 8 0.0003
889 PRURITUS 125 0.0003
890 RHINORRHOEA 21 0.0003
891 DEPRESSED MOOD 17 0.0003
892 FATIGUE 248 0.0003
893 HYPOTHYROIDISM 10 0.0003
894 CHROMATURIA 7 0.0003
895 HEART RATE IRREGULAR 7 0.0003
896 SKIN ULCER 8 0.0003
897 DYSTONIA 6 0.0003
898 EAR PAIN 6 0.0003
899 ASTHENIA 116 0.0003
900 DIPLOPIA 8 0.0003
901 INCORRECT ROUTE OF DRUG ADMINISTRATION 11 0.0003
902 DEAFNESS 8 0.0003
903 VISUAL ACUITY REDUCED 10 0.0003
904 ABORTION SPONTANEOUS 12 0.0003
905 BURNING SENSATION 21 0.0003
906 CARDIAC FAILURE CONGESTIVE 24 0.0003
907 MENSTRUATION IRREGULAR 8 0.0003
908 OCULAR HYPERAEMIA 14 0.0003
909 INTESTINAL OBSTRUCTION 11 0.0003
910 GASTRIC DISORDER 10 0.0003
911 CHRONIC KIDNEY DISEASE 22 0.0003
912 NERVOUS SYSTEM DISORDER 9 0.0003
913 GASTROOESOPHAGEAL REFLUX DISEASE 23 0.0003
914 MOBILITY DECREASED 20 0.0003
915 EYE DISORDER 9 0.0003
916 DRUG INTOLERANCE 26 0.0003
917 ASTHMA 30 0.0003
918 NEPHROLITHIASIS 12 0.0003
919 EMOTIONAL DISORDER 8 0.0003
920 OVERDOSE 55 0.0003
921 CYSTITIS 8 0.0003
922 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 12 0.0002
923 PAIN IN JAW 7 0.0002
924 AMNESIA 16 0.0002
925 INFLUENZA LIKE ILLNESS 20 0.0002
926 DEPRESSION 55 0.0002
927 MUSCULOSKELETAL STIFFNESS 21 0.0002
928 EMOTIONAL DISTRESS 29 0.0002
929 GAIT INABILITY 8 0.0002
930 THERAPY INTERRUPTED 17 0.0002
931 FEELING ABNORMAL 57 0.0002
932 FLUID RETENTION 12 0.0002
933 BALANCE DISORDER 20 0.0002
934 ARTHRITIS 18 0.0002
935 INJECTION SITE RASH 7 0.0002
936 DEATH 196 0.0002
937 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
938 NEOPLASM MALIGNANT 15 0.0002
939 UNDERDOSE 16 0.0002
940 LUNG NEOPLASM MALIGNANT 9 0.0002
941 OSTEONECROSIS 7 0.0002
942 DYSSTASIA 6 0.0002
943 ILL-DEFINED DISORDER 12 0.0002
944 THERAPY CESSATION 10 0.0002
945 OSTEOPOROSIS 8 0.0002
946 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
947 RENAL DISORDER 9 0.0002
948 MEMORY IMPAIRMENT 26 0.0002
949 RHEUMATOID ARTHRITIS 21 0.0002
950 CATARACT 11 0.0002
951 ACNE 14 0.0002
952 BREAST CANCER 17 0.0002
953 COLITIS ULCERATIVE 8 0.0002
954 PRODUCT DOSE OMISSION ISSUE 52 0.0002
955 DRY MOUTH 14 0.0002
956 PSORIATIC ARTHROPATHY 7 0.0002
957 INCORRECT DOSE ADMINISTERED 39 0.0002
958 DEVICE EXPULSION 11 0.0002
959 WITHDRAWAL SYNDROME 7 0.0002
960 ALOPECIA 32 0.0002
961 ARTHROPATHY 9 0.0002
962 THROAT IRRITATION 7 0.0002
963 SLEEP DISORDER 11 0.0002
964 ADVERSE EVENT 14 0.0002
965 DRUG EFFECT DECREASED 8 0.0001
966 DRUG WITHDRAWAL SYNDROME 13 0.0001
967 DRY SKIN 19 0.0001
968 SKIN EXFOLIATION 12 0.0001
969 INTENTIONAL PRODUCT MISUSE 12 0.0001
970 DYSGEUSIA 10 0.0001
971 DERMATITIS ATOPIC 7 0.0001
972 BLOOD GLUCOSE INCREASED 25 0.0001
973 VERTIGO 8 0.0001
974 INJECTION SITE REACTION 9 0.0001
975 INJECTION SITE SWELLING 10 0.0001
976 BLOOD CHOLESTEROL INCREASED 6 0.0001
977 HOSPITALISATION 19 0.0001
978 INJECTION SITE PAIN 37 0.0001
979 DRY EYE 6 0.0001
980 CARDIAC DISORDER 11 0.0001
981 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
982 INJECTION SITE ERYTHEMA 14 0.0001
983 DEVICE ISSUE 10 0.0001
984 INJECTION SITE BRUISING 8 0.0001
985 ADVERSE DRUG REACTION 9 0.0001
986 INJECTION SITE HAEMORRHAGE 8 0.0001
987 DRUG ABUSE 8 0.0001
988 PRODUCT QUALITY ISSUE 13 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
990 PSORIASIS 9 0.0001
991 DRUG DEPENDENCE 6 0.0000